Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1972 Jan;10(1):89–102.

Liver specific antigens: purification and characterization

K H Meyer Zum Büschenfelde, P A Miescher
PMCID: PMC1713098  PMID: 4622787

Abstract

Human liver has been homogenated and submitted to 150,000 g in order to investigate the supernatant for the presence of liver specific antigens. Gel-filtration on Sephadex G-100 revealed liver specific antigenicity in the first peak. Gel-filtration of the first peak on Sephadex G-200 revealed two peaks each exhibiting liver specific antigenicity. Immunochemical and physicochemical analysis made it possible to define the liver-specific antigen present in the first peak as a lipoprotein with the characteristics of a high molecular weight, low density protein. It is partly located in the membrane of liver cells. The liver specific protein of the second Sephadex G-200 peak has a molecular weight of about 190,000. It is located within the cytoplasm of hepatocytes.

Full text

PDF
89

Images in this article

98Fig. 6
on p.98
99Fig. 7
on p.99
100Fig. 8
on p.100

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AGGLUTINATION-INHIBITION test proposed as a standard of reference in influenza diagnostic studies; Committee on Standard Serological Procedures in Influenza Studies. J Immunol. 1950 Sep;65(3):347–353. [PubMed] [Google Scholar]
  2. Berg P. A., Doniach D., Roitt I. M. Immunologische Phänomene bei Leberkrankheiten: Die Bedeutung mitochondrialer Antikörper. Klin Wochenschr. 1969 Dec 15;47(24):1297–1307. doi: 10.1007/BF01484292. [DOI] [PubMed] [Google Scholar]
  3. D'AMELIO V., PERLMANN P. The distribution of soluble antigens in cellular structures of rat liver. Exp Cell Res. 1960 Mar;19:383–398. doi: 10.1016/0014-4827(60)90016-1. [DOI] [PubMed] [Google Scholar]
  4. Dumonde D. C. Tissue-specific antigens. Adv Immunol. 1966;5:245–412. doi: 10.1016/s0065-2776(08)60275-8. [DOI] [PubMed] [Google Scholar]
  5. HOFMANN A. F., BORGSTROM B. Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed Proc. 1962 Jan-Feb;21:43–50. [PubMed] [Google Scholar]
  6. Kössling F. K., Meyer zum Büschenfelde Untersuchungen zur Pathogenese der aktiven chronischen Hepatitis. Z Gesamte Exp Med. 1970;153(2):150–161. [PubMed] [Google Scholar]
  7. Kössling F. K., Meyer zum Büschenfelde Zur Induktion einer aktiven chronischen Hepatitis durch heterologe lösliche Leberproteine. Virchows Arch A Pathol Pathol Anat. 1968;345(4):365–376. [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. Licht W. Zur Frage leberspezifischer Antigene beim Menschen. Klin Wochenschr. 1966 Jul 15;44(14):833–837. doi: 10.1007/BF01711502. [DOI] [PubMed] [Google Scholar]
  10. Meyer Zum Büschenfelde Untersuchungen über die immunbiologische Bedeutung löslicher Leberproteine. Z Gesamte Exp Med. 1968;148(2):131–163. [PubMed] [Google Scholar]
  11. Meyer zum Büschenfelde Immunosuppressive Therapie der chronischen Hepatitis. Dtsch Med J. 1969 Aug;20(16):522–527. [PubMed] [Google Scholar]
  12. Meyer zum Büschenfelde Klinische Untersuchungen zur immunologischen Spezifität des Leberparenchyms. Arch Klin Med. 1968;215(2):107–132. [PubMed] [Google Scholar]
  13. Meyer zum Büschenfelde, Kössling F. K. Untersuchungen über die immunbiologische Bedeutung löslicher Leberproteine. Verh Dtsch Ges Inn Med. 1968;74:529–533. [PubMed] [Google Scholar]
  14. Meyer zum Büschenfelde, Schrank C. Untersuchungen zur Frage organspezifischer Antigene der Leber. Klin Wochenschr. 1966 Jun 1;44(11):654–656. doi: 10.1007/BF01745901. [DOI] [PubMed] [Google Scholar]
  15. PERLMANN P., D'AMELIO V. Soluble antigens in microsomes and other cell-fractions of rat liver. Nature. 1958 Feb 15;181(4607):491–492. doi: 10.1038/181491a0. [DOI] [PubMed] [Google Scholar]
  16. SCHEIDEGGER J. J. Une micro-méthode de l'immuno-electrophorèse. Int Arch Allergy Appl Immunol. 1955;7(2):103–110. [PubMed] [Google Scholar]
  17. Schumacher K., Koch W. Nachweis zirkulierender Auto-Antikörper bei chronisch-progressiver Hepatitis. Klin Wochenschr. 1968 Sep 1;46(17):925–929. doi: 10.1007/BF01747156. [DOI] [PubMed] [Google Scholar]
  18. THOMSON J. F., MIKUTA E. T. Enzymatic activity of cytoplasmic particulates of rat liver isolated by gradient centrifugation. Arch Biochem Biophys. 1954 Aug;51(2):487–498. doi: 10.1016/0003-9861(54)90504-4. [DOI] [PubMed] [Google Scholar]
  19. VOGT P. K. [The immunology of liver microsomes. III. The localization of tissue-specific antigens within the structural components of endoplastic reticulum]. Z Naturforsch B. 1960 Apr;15B:221–225. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES